前十大流通股东累计持有： 7523.1万股，累计占流通股比： 35.51%，较上期变化： 95.71万股。 一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0271 | 0.0086 | 215.12 | -0.0475 | | 每股净资产（元） | 3.98 | 3.78 | 5.29 | 3.94 | | 每股公积金(元) | 1.16 | 1.16 | 0 | 1.16 | | 每股未分配利润(元) | 1.29 | 1.11 | 16.22 | 1.25 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.43 | 1.57 | -8.92 | 1.39 | | 净利润(亿元) | 0.07 | 0.02 | 250 | -0.12 | | 净资产收益率(%) | 0.68 | 0.23 | 195.65 | -1.20 | 数据四舍五入，查看更多财务数据>> 二、前10名 ...

Financial Performance - The company reported a basic earnings per share of 0.0800 yuan for Q1 2025, a 300% increase compared to 0.0200 yuan in Q1 2024 [1] - Net profit for Q1 2025 reached 1.04 billion yuan, showing a significant increase of 447.37% from 0.19 billion yuan in Q1 2024 [1] - The return on equity (ROE) improved to 2.20% in Q1 2025, up from 0.47% in Q1 2024, marking a 368.09% increase [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 74,696.93 million shares, accounting for 59% of the circulating shares, with a decrease of 400.27 million shares compared to the previous period [1] - Ningbo Jihong Holding Group Co., Ltd. remains the largest shareholder with 26,925.66 million shares, representing 21.27% of the total share capital [2] - The second-largest shareholder, WING SING INTERNATIONAL CO., LTD., holds 14,688.00 million shares, which is 11.60% of the total [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares in this period [3]

一、主要会计数据和财务指标 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 46299.58万股，累计占流通股比： 49.07%，较上期变化： 13.43万股。 | 名称 | 持有数量(万股) | 占总股本 | 增减情况 | | --- | --- | --- | --- | | | | 比例(%) | (万股) | | 安徽华茂集团有限公司 | 43786.06 | 46.41 | 不变 | | 浙江恒河实业集团有限公司 | 509.05 | 0.54 | 不变 | | 林正德 | 328.84 | 0.35 | -13.03 | | 沈汉江 | 303.38 | 0.32 | 不变 | | 武汉市信德置业投资发展有限公司 | 290.63 | 0.31 | 不变 | | 丁桂飞 | 245.69 | 0.26 | 16.08 | | 中信建投（601066）证券-中国中信金融资产管理股份有限公 | | | | | 司-中信建投-先锋单一资产管理计划 | 223.81 | 0.24 | 新进 | | 沈志径 | 210.62 | 0.22 | 2.85 | | 田菁 | 201.50 | 0. ...

前十大流通股东累计持有： 60248.54万股，累计占流通股比： 32.07%，较上期变化： -108.45万股。 | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | --- | --- | --- | --- | | 诸暨市水务集团有限公司 | 52415.80 | 27.91 | 不变 | | 海口慧平广告有限公司 | 1824.09 | 0.97 | 不变 | | 王洪海 | 1243.85 | 0.66 | -68.64 | | 中国包装进出口有限责任公司 | 879.84 | 0.47 | 不变 | | 傅燕萍 | 751.97 | 0.40 | -8.70 | | 邹立英 | 704.32 | 0.37 | 新进 | | 马风兰 | 619.37 | 0.33 | 新进 | | 吴晓旗 | 605.00 | 0.32 | 不变 | | 香港中央结算有限公司 | 604.30 | 0.32 | 新进 | | 李绪坤 | 600.00 | 0.32 | 新进 | | | 较上个报告期退出前十大股东有 | | | | 王秀平 | 874.85 | 0.47 | 退出 | ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0541 | -0.0479 | 212.94 | -0.1028 | | 每股净资产（元） | 5.6 | 6.12 | -8.5 | 6.55 | | 每股公积金(元) | 2.81 | 2.81 | 0 | 2.81 | | 每股未分配利润(元) | 1.66 | 2.17 | -23.5 | 2.61 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 14.36 | 12.09 | 18.78 | 17.64 | | 净利润(亿元) | 0.31 | -0.28 | 210.71 | -0.59 | | 净资产收益率(%) | 0.93 | -0.75 | 224 | -1.49 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 27270.14万股，累计占流通股比： 53.1 ...

一、主要会计数据和财务指标 本次公司不分配不转赠。 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 77513.98万股，累计占流通股比： 56.23%，较上期变化： 22027.47万股。 | 名称 | 持有数量(万股) | 占总股本比 | 增减情况 | | --- | --- | --- | --- | | | | 例(%) | (万股) | | 新疆中新建能源矿业有限责任公司 | 36092.25 | 26.18 | 不变 | | 阿拉尔市国有资本投资运营集团有限公司 | 26635.87 | 19.32 | 22591.36 | | 全国社保基金五零三组合 | 4200.00 | 3.05 | -0.01 | | 易方达基金-中央汇金资产管理有限责任公司-易方达基金 | | | | | 汇金资管单一资产管理计划 | 3408.00 | 2.47 | 不变 | | 张素芬 | 2210.00 | 1.60 | 220.00 | | 曹嘉朋 | 1065.48 | 0.77 | 不变 | | 新疆生产建设兵团投资有限责任公司 | 1030.00 | 0.75 | 不变 | | 孙沈侠 | 1 ...

前十大流通股东累计持有： 29234.05万股，累计占流通股比： 37.97%，较上期变化： 250.25万股。 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0493 | 0.0043 | -1246.51 | 0.1078 | | 每股净资产（元） | 3.71 | 5.12 | -27.54 | 5.25 | | 每股公积金(元) | 1.09 | 1.09 | 0 | 1.09 | | 每股未分配利润(元) | 1.25 | 2.67 | -53.18 | 2.80 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 8.67 | 13.43 | -35.44 | 16.82 | | 净利润(亿元) | -0.38 | 0.03 | -1366.67 | 0.83 | | 净资产收益率(%) | -1.32 | 0.08 | -1750 | 2.07 | 数据四舍五入，查看更多财务数据>> 二、前10 ...

Financial Performance - The company reported a basic earnings per share of -0.0500 yuan for Q1 2025, an improvement of 28.57% compared to -0.0700 yuan in Q1 2024 [1] - The total revenue for Q1 2025 was 10.7 billion yuan, representing a 12.28% increase from 9.53 billion yuan in Q1 2024 [1] - The net profit for Q1 2025 was -0.54 billion yuan, showing a 23.94% improvement from -0.71 billion yuan in Q1 2024 [1] - The return on equity for Q1 2025 was -1.06%, an improvement from -1.28% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 57,163.5 million shares, accounting for 55.57% of the circulating shares, with an increase of 898.95 million shares compared to the previous period [1] - Shanghai Jiushi (Group) Co., Ltd. remains the largest shareholder with 37,376.75 million shares, representing 36.34% of the total share capital [2] - New entrants among the top shareholders include Wu Hongbin, Cheng Yiqing, Liu Zhiqiang, and Chen Weixing, while Qin Huiyu, Zhou Yue, Chen Yajing, and Zhu Yushu have exited the top ten shareholders [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [3]

Core Viewpoint - The company, Northeast Pharmaceutical Group Co., Ltd., has disclosed its quarterly report, ensuring the accuracy and completeness of the financial information presented, and has not undergone an audit for this report [1][2][13]. Financial Data Summary - The company reported a significant increase in other current assets, with a year-end balance of 34.68 million yuan, reflecting a 31% growth compared to the beginning of the year, primarily due to changes in tax payments [4]. - The balance of notes payable decreased to 2.05 billion yuan, a reduction of 42% from the beginning of the year, attributed to a decrease in issued notes [5]. - The payable to employees dropped to 2.62 million yuan, down 94% from the beginning of the year, due to a reduction in employee compensation [5]. - The balance of taxes payable was 54.97 million yuan, a decrease of 31% from the beginning of the year, influenced by tax payments made during the period [5]. - Research and development expenses amounted to 32 million yuan, an increase of 88% year-on-year, indicating a higher investment in R&D [5]. - Financial expenses were reported at -7.68 million yuan, a decrease of 32% year-on-year, due to reduced interest expenses on bank loans [5]. - Investment income was 1.35 million yuan, down 41% year-on-year, primarily due to a decrease in debt restructuring amounts [5]. - The company reported a significant reduction in credit impairment losses, amounting to -5.87 million yuan, a decrease of 2380% year-on-year, due to an increase in accounts receivable [5]. - The asset impairment loss was -64.44 million yuan, a decrease of 71% year-on-year, attributed to an increase in inventory write-down provisions [5]. - The company recorded a net cash inflow from the disposal of fixed assets of 30,000 yuan, a decrease of 92% year-on-year, indicating reduced cash recovery from asset disposals [8]. - Cash received from bank borrowings was 14.4 billion yuan, an increase of 157% year-on-year, reflecting higher bank loan receipts [9]. - Cash paid for debt repayment was 9.92 billion yuan, an increase of 183% year-on-year, due to increased cash outflows for loan repayments [9]. Legal Matters - The company is involved in a legal dispute with a claim for economic damages of 32.7 million yuan and additional interest losses of approximately 25.15 million yuan, totaling 57.85 million yuan [15][16]. - The case has been accepted by the court and is scheduled for a hearing on May 12, 2025 [17]. - The company has stated that there are no other undisclosed significant litigation or arbitration matters as of the announcement date [18].

Core Viewpoint - The company has disclosed its first-quarter report for 2025, ensuring the accuracy and completeness of the financial information presented, with no significant omissions or misleading statements [2][10][20]. Financial Data Summary - The company reported a 36.66% decrease in cash and cash equivalents compared to the beginning of the period, primarily due to reduced sales collections and repayment of bank loans [4]. - Prepayments increased by 94.28%, attributed to higher advance payments for raw material purchases [4]. - Accounts payable decreased by 48.55%, mainly due to payments made for raw materials [4]. - Net cash flow from operating activities decreased by 105.36% year-on-year, resulting from a decline in revenue [5]. - Net cash flow from investing activities increased by 1.0988 million yuan year-on-year, due to the recovery of external investment funds [5]. - Net cash flow from financing activities increased by 62.43% year-on-year, primarily due to a reduction in bank loan repayments [5]. - Employee compensation payable decreased by 66.89% compared to the beginning of the period, due to the distribution of last year's performance bonuses [7]. - Tax payable decreased by 34.97%, mainly due to a reduction in value-added tax [7]. - Research and development expenses decreased by 38.34% year-on-year, attributed to reduced investment in R&D projects [7]. - Investment income decreased by 63.36% year-on-year, mainly due to a reduction in discount interest on notes [7]. Shareholder Information - The company has not reported any changes in the top ten shareholders or any significant shareholder lending activities [5]. Other Important Matters - The company is actively pursuing the recovery of external investment funds, with a total of 31.7482 million yuan owed by a partner, which has led to arbitration proceedings due to non-payment [6]. - A wholly-owned subsidiary has provided a guarantee for a financing loan of up to 5 million yuan from China Everbright Bank [7]. Board and Supervisory Meetings - The board of directors and the supervisory board have both approved the first-quarter report, confirming that the report complies with legal and regulatory requirements [12][20]. - The company has appointed a new securities affairs representative, Zhou Zexu, whose qualifications meet the necessary regulatory standards [24][26].